Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the safety and efficacy of SBRT in LAPC with different
biological effective dose (BED) (60-70Gy Vs.>70Gy ) , to identify a dose range that could
achieve better survival benefit and minimize the toxicity of radiotherapy.